Page last updated: 2024-08-24

ranolazine and Lung Neoplasms

ranolazine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altun, S; Bugan, I; Djamgoz, MBA; Dodson, A; Foster, CS; Fraser, SP; Karagoz, Z; Kaya, H; Kucuk, S	1

Other Studies

1 other study(ies) available for ranolazine and Lung Neoplasms

Article	Year
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate. Prostate cancer and prostatic diseases, 2019, Volume: 22, Issue:4 Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; NAV1.7 Voltage-Gated Sodium Channel; Prostate; Prostatic Neoplasms; Ranolazine; Rats; Tissue Array Analysis; Voltage-Gated Sodium Channel Blockers	2019

Article

Year

Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.

Prostate cancer and prostatic diseases, 2019, Volume: 22, Issue:4

Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; NAV1.7 Voltage-Gated Sodium Channel; Prostate; Prostatic Neoplasms; Ranolazine; Rats; Tissue Array Analysis; Voltage-Gated Sodium Channel Blockers

2019